Parnax Lab Ltd. engages in manufacturing and trading of pharmaceuticals and medicinal products. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2009-09-15. The firm is principally engaged in the business activities of manufacturing and export of pharmaceutical formulations. The company is also focused on the trading of pharmaceuticals and medicinal products. The firm operates through dealing in the pharmaceutical formulations segment. The company is engaged in developing and delivering huge volumes of oral formulations, such as cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme preparations, pediatric formulations, special formulations for geriatrics, highly viscous products, suspensions and others. The Company’s subsidiary is Naxpar Pharma Private Limited.
Loading chart…
Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:
The headline call - descriptive label, conviction, and the synthesis behind it.
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Forensic and governance risk pointers, severity-ranked.
Solvency and earnings-quality score.
Quarter-by-quarter earnings-call briefs - what changed and why.